Important Safety Information for Mozobil (plerixafor injection) Severe, life-threatening allergic reactions (anaphylaxis) can happen in people who take Mozobil.
Mozobil helps patients with non-Hodgkin's lymphoma by releasing stem cells that can be collected and transplanted back. Learn about side effects, interactions and ...
Mozobil official prescribing information for healthcare professionals. Includes: indications, dosage, adverse reactions, pharmacology and more.
Plerixafor (INN and USAN, trade name Mozobil) is an immunostimulant used to mobilize hematopoietic stem cells in cancer patients into the bloodstream.
Learn more about Mozobil (plerixafor injection).Please see important safety and prescribing information for Mozobil (plerixafor injection).
Mozobil (plerixafor injection) is a sterile, preservative-free, clear, colorless to pale yellow, isotonic solution for subcutaneous injection.
These highlights do not include all the information needed to use MOZOBIL safely and effectively. See full prescribing information for MOZOBIL.
In pharmacodynamic studies of Mozobil in healthy volunteers, peak mobilization of CD34+ cells was observed between 6 and 9 hours after administration.
Brand name: Mozobil™ Approved for non-Hodgkin lymphoma and multiple myeloma; Full prescribing information is available, including clinical trial information, safety ...
This page contains brief information about plerixafor and a collection of links to more information about the use of this drug, research results, and ongoing clinical ...